University of North Texas Health Science Center to Repay Government $13 Million

The research center and medical school admittedly violated the rules in spending grants from the National Institutes of Health.

Written byAshley Yeager
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, MICHAEL BARERAThe University of North Texas (UNT) Health Science Center will pay the US government more than $13 million in reparations for mistakes made in spending money from National Institutes of Health (NIH) grants.

The research center and medical school, located in Fort Worth, Texas, discovered the errors in 2015, disclosed them to the government, and agreed to repay the money in a settlement last Friday (February 16), the Star-Telegram reports. From January 2011 through February 2016, the center made errors logging researchers’ time working on grant projects and overpaid them. The center cooperated in the investigation of the errors and in the settlement process, according to a statement released by the US Attorney’s Office in the North District of Texas.

“Integrity is one of our core values, and that means owning, correcting and learning from our mistakes,” UNT Health Science Center President Michael Williams says in a media release. “We’ve strengthened our internal controls to promote accountability and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies